Site Logo

Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.

UBC Joins New Industry Coalition: Decentralized Trials & Research Alliance (DTRA)

UBC is proud to be a founding member of the DTRA and accelerate the broad adoption of patient-focused, decentralized clinical trials and research.

In the wake of the COVID-19 health crisis, the entire biopharmaceutical industry is coming together to ensure the advancement of patient access to critical research studies and novel treatments. Together, we are working to remove barriers to make trial and research access safe and convenient, by accelerating the adoption of technology-enabled remote data collection practices.

“We are honored to join the DTRA at such a pivotal moment for the entire healthcare system. The pandemic has presented myriad challenges for pharmaceutical manufacturers, research organizations, and regulators” said Aaron Berger, Executive Director, Late Stage Operations & RWE, a leading voice in evidence generation strategies. “To meet these challenges, a robust array of decentralized trial solutions is needed including digital patient engagement, technology-enabled data acquisition, and in-home nursing. We are introducing one or more of these strategies into study design discussions with our sponsor partners.”

Since March, UBC’s comprehensive suite of solutions has helped many clients mitigate the risks that surround bringing treatments to market in today’s challenging environment.

“Through the utilization of direct-to-patient and digital strategies, we have been able to modernize and accelerate the way we gather critical data and insights needed for regulatory decisions and beyond. Our wide array of decentralized study capabilities to collect critical evidence beyond the walls of the traditional study setting, remotely or in the patient’s home. These are the type of experiences we are keen to share with fellow leaders and industry stakeholders as part of our role in the DTRA and the future of clinical development.” Berger concludes.

About DTRA:
The Decentralized Trials & Research Alliance (DTRA) was convened to enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research. It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods.

For more information regarding UBC’s virtual & decentralized research solutions, head here.